Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB

Maximilian Wübbolding, Juan Carlos Lopez Alfonso, Chun‐Yen Lin, Sebastian Binder, Christine Falk, Jennifer Debarry, Paul Gineste, Anke R.M.

Addressing Social Determinants of Liver Disease During the COVID‐19 Pandemic and Beyond: A Call to Action

Ani Kardashian, Julius Wilder, Norah A. Terrault, Jennifer C. Price – 4 November 2020 – The COVID‐19 pandemic has exposed healthcare inequities in the USA and highlighted the importance of social conditions in shaping the health of persons. In the field of hepatology, social determinants of health (SDOH) are closely linked to disparities in liver disease prevalence, outcomes, and access to treatment.

Subscribe to